ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)
ExonHit Therapeutics hopes to commercialize a microarray-based clinical test for diagnosing Alzheimer’s disease in Europe by the first quarter of next year, the company said this week.
More:
ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)
Related posts:
- Researchers Publish Data on Gene Variant Associated with Late-Onset Alzheimer’s Disease (GenomeWeb News) Newly published data on a gene variant associated with late onset of Alzheimer's disease serves as an open invitation to research institutes to independently validate this link and may provide...
- Test improves Alzheimer diagnosis (BBC News) A multi-tasking test can help avoid confusion between symptoms of depression and early Alzheimer's, a study finds....
- Sea Squirt Helps Researchers Test New Alzheimer’s Drug (HealthDay via Yahoo! News) TUESDAY, March 2 (HealthDay News) -- The humble sea squirt may offer a new way to test drugs to treat Alzheimer's disease, U.S. researchers say....
- Imaging Test Detects Alzheimer’s Disease That Is Likely To Progress (Medical News Today) Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue...
- Alzheimer Drug Test Result From J&J May Be Pushed Back to 2012 (Bloomberg) March 18 (Bloomberg) -- One of the most eagerly anticipated studies of a drug for Alzheimer’s disease may not yield results until 2012, two years later than had been forecast....